10-Q/A Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q3 2013

Filing Information

Form Type	10-Q/A
Accession Number	`0001144204-13-062733`
Period End Date	20130930
Filing Date	20131118
Fiscal Year	2013
Fiscal Period	Q3
XBRL Instance	bpth-20130930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 62 Cash Flow Statement 73

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$952.25K	USD	Point-in-time
Cash	`Cash`	$332.86K	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	-	USD	Point-in-time
Cash	`Cash`	$4.10M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$534.05K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$148.30K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$195.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$49.71K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$42.58K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.30M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$771.62K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	75.38M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	62.22M	shares	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	75.38M	shares	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	62.22M	shares	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$928.23K	USD	Point-in-time
Additional paid in capital for shares to be issued, shares of common stock	`CommonStockIssuableSharesIssuable`	8.05M	shares	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.05M	USD	Point-in-time
Additional paid in capital for shares to be issued, shares of common stock	`CommonStockIssuableSharesIssuable`	2.54M	shares	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.45M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.57M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.34M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$5.75M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$43.58K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$57.00K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	-	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	$8.58K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	$8.58K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$137.66K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$28.12K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$52.05K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$26.00K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$50.00K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$100.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$173.75K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$329.24K	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$329.24K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$173.75K	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 75,380,214 and 62,219,050 shares issued and outstanding as of 9/30/13 and 12/31/12, respectively	`CommonStockValue`	$75.38K	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 75,380,214 and 62,219,050 shares issued and outstanding as of 9/30/13 and 12/31/12, respectively	`CommonStockValue`	$62.22K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$13.32M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$16.89M	USD	Point-in-time
Additional paid in capital for shares to be issued	`OtherAdditionalCapital`	$3.22M	USD	Point-in-time
Additional paid in capital for shares to be issued	`OtherAdditionalCapital`	$762.51K	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$14.61M	USD	Point-in-time
Accumulated deficit during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$12.13M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$5.58M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$2.01M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$5.75M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$2.34M	USD	Point-in-time

Income Statement 62 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	3 Qtrs
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	3 Qtrs
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	26 Qtrs
Amortization expenses	`AdjustmentForAmortization`	$145.12K	USD	3 Qtrs
Amortization expenses	`AdjustmentForAmortization`	$120.47K	USD	3 Qtrs
Amortization expenses	`AdjustmentForAmortization`	$1.10M	USD	26 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$729.57K	USD	3 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$1.29M	USD	3 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$8.35M	USD	26 Qtrs
General & administrative	`GeneralAndAdministrativeExpense`	$246.09K	USD	1 Quarter
General & administrative	`GeneralAndAdministrativeExpense`	$810.15K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$2.15M	USD	3 Qtrs
Total operating expense	`OperatingExpenses`	$14.93M	USD	26 Qtrs
Technology impairment charge	`OtherAssetImpairmentCharges`	$345.00K	USD	Annual
Total operating expense	`OperatingExpenses`	$1.39M	USD	1 Quarter
Technology impairment charge	`OtherAssetImpairmentCharges`	-	USD	3 Qtrs
Technology impairment charge	`OtherAssetImpairmentCharges`	$690.00K	USD	26 Qtrs
Total operating expense	`OperatingExpenses`	$2.48M	USD	3 Qtrs
Technology impairment charge	`OtherAssetImpairmentCharges`	$345.00K	USD	3 Qtrs
Total operating expense	`OperatingExpenses`	$840.49K	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-2.15M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-14.93M	USD	26 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-2.48M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-840.49K	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.39M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$837.00	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$26.00	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$768.00	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$79.58K	USD	26 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.49K	USD	3 Qtrs
Other income	`OtherNonoperatingIncome`	-	USD	3 Qtrs
Other income	`OtherNonoperatingIncome`	-	USD	3 Qtrs
Other income	`OtherNonoperatingIncome`	$244.48K	USD	26 Qtrs
Other income	`OtherNonoperatingIncome`	-	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	-	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$316.00	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$4.83K	USD	26 Qtrs
Other expense	`OtherNonoperatingExpense`	$89.00	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$661.00	USD	3 Qtrs
Other expense	`OtherNonoperatingExpense`	$487.00	USD	3 Qtrs
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$281.00	USD	3 Qtrs
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$-63.00	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$1.83K	USD	3 Qtrs
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$521.00	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$319.23K	USD	26 Qtrs
Net Loss	`NetIncomeLoss`	$-840.55K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-2.15M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-2.48M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-14.61M	USD	26 Qtrs
Net Loss	`NetIncomeLoss`	$-1.39M	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	3 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	3 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.30	USD	26 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	58.72M	shares	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	48.62M	shares	26 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	58.90M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	75.38M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	68.07M	shares	3 Qtrs

Cash Flow Statement 73 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-840.55K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.15M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.48M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-14.61M	USD	26 Qtrs
Net loss	`NetIncomeLoss`	$-1.39M	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$145.12K	USD	3 Qtrs
Amortization	`AdjustmentForAmortization`	$120.47K	USD	3 Qtrs
Amortization	`AdjustmentForAmortization`	$1.10M	USD	26 Qtrs
Technology impairment	`OtherAssetImpairmentCharges`	$345.00K	USD	Annual
Technology impairment	`OtherAssetImpairmentCharges`	-	USD	3 Qtrs
Technology impairment	`OtherAssetImpairmentCharges`	$690.00K	USD	26 Qtrs
Technology impairment	`OtherAssetImpairmentCharges`	$345.00K	USD	3 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$318.50K	USD	26 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$346.20K	USD	1 Quarter
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	3 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$708.60K	USD	1 Quarter
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$18.50K	USD	3 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$795.00K	USD	1 Quarter
Stock options and warrants	`ShareBasedCompensation`	$45.48K	USD	3 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$635.60K	USD	3 Qtrs
Stock options and warrants	`ShareBasedCompensation`	$3.65M	USD	26 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$148.30K	USD	26 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$-46.70K	USD	3 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$-73.50K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$7.14K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-3.04K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$49.71K	USD	26 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-155.49K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$173.75K	USD	26 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-47.56K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.84M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.57M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.88M	USD	26 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$884.71K	USD	26 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$25.00K	USD	3 Qtrs
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	-	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-25.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-884.71K	USD	26 Qtrs
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	-	USD	3 Qtrs
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	$435.00K	USD	26 Qtrs
Proceeds from convertible notes	`ProceedsFromConvertibleDebt`	-	USD	3 Qtrs
Cash repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$15.00K	USD	26 Qtrs
Cash repayment of convertible notes	`RepaymentsOfConvertibleDebt`	-	USD	3 Qtrs
Cash repayment of convertible notes	`RepaymentsOfConvertibleDebt`	-	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$973.15K	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$5.40M	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$13.44M	USD	26 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.86M	USD	26 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.40M	USD	3 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$973.15K	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$-619.39K	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$4.10M	USD	26 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$3.57M	USD	3 Qtrs
Cash, beginning of period	`Cash`	$952.25K	USD	Point-in-time
Cash, beginning of period	`Cash`	$332.86K	USD	Point-in-time
Cash, beginning of period	`Cash`	-	USD	Point-in-time
Cash, beginning of period	`Cash`	$4.10M	USD	Point-in-time
Cash, beginning of period	`Cash`	$534.05K	USD	Point-in-time
Cash, end of period	`Cash`	$952.25K	USD	Point-in-time
Cash, end of period	`Cash`	$332.86K	USD	Point-in-time
Cash, end of period	`Cash`	-	USD	Point-in-time
Cash, end of period	`Cash`	$4.10M	USD	Point-in-time
Cash, end of period	`Cash`	$534.05K	USD	Point-in-time
Interest	`InterestPaid`	-	USD	3 Qtrs
Interest	`InterestPaid`	-	USD	3 Qtrs
Interest	`InterestPaid`	$445.00	USD	26 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	26 Qtrs
Income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Common stock issued upon conversion of convertible notes	`ConversionOfStockAmountConverted1`	-	USD	3 Qtrs
Common stock issued upon conversion of convertible notes	`ConversionOfStockAmountConverted1`	-	USD	3 Qtrs
Common stock issued upon conversion of convertible notes	`ConversionOfStockAmountConverted1`	$420.00K	USD	26 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.